Navigation Links
Thermage Schedules Shareholder Meeting for Vote on the Issuance of Common Stock in Connection With the Reliant Acquisition
Date:11/24/2008

HAYWARD, Calif., Nov. 24 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM) today announced that its S-4 Registration Statement, filed with the Securities and Exchange Commission regarding its proposed acquisition of Reliant, Inc., has been declared effective. The proxy will be mailed beginning on or about November 25, 2008 to shareholders of record as of October 31, 2008. The Company has set a date of Tuesday, December 23 for a meeting of its shareholders to vote on the issuance of common stock in connection with the proposed acquisition. The meeting will be held at Thermage's corporate offices at 25881 Industrial Boulevard, Hayward, California 94545 at 9:00 a.m. PST.

"Scheduling the shareholder meeting was a significant step, and we are very happy to be moving forward to complete this transaction, which we believe offers many benefits to our customers and shareholders," said Stephen J. Fanning, Chairman of the Board, President and CEO of Thermage. "The proposed transaction combines two well-recognized and respected brands in the aesthetics device industry. Both Thermage and Reliant are known for their innovation and our combination will offer opportunities for an expanded market presence through the cross-selling of our products. Both of our business models generate substantial recurring revenue. Finally, we have identified significant cost savings that should enhance the efficiency of our operations. We are very excited about this transaction and, pending shareholder approval, are on-track to close by year-end."

About Thermage

Thermage's innovative technology provides a unique non-invasive procedure designed to tighten and contour skin, significantly expanding the non-invasive aesthetic applications physicians can offer to the rapidly growing "anti-aging" market. For more information about Thermage, call 1-510-259-7117 or log on to http://www.thermage.com.

Additional Information and Where You Can Find It

This communication may be deemed to be solicitation material in respect of the proposed transaction between Thermage and Reliant. In connection with the transaction, Thermage has filed a registration statement on Form S-4 with the SEC containing a proxy statement/prospectus/ information statement. The proxy statement/prospectus/information statement will be mailed to the stockholders of Thermage and Reliant. Investors and security holders of Thermage and Reliant are urged to read the proxy statement/prospectus/information statement when it becomes available because it will contain important information about Thermage, Reliant and the proposed transaction. The proxy statement/prospectus/information statement (when it becomes available), and any other documents filed by Thermage with the SEC, may be obtained free of charge at the SEC's web site at http://www.sec.gov. In addition, investors and security holders may obtain free copies of the documents filed with the SEC by Thermage by contacting Thermage Investor Relations by e-mail at IR@thermage.com or by telephone at (510) 259-7117. Investors and security holders are urged to read the proxy statement/prospectus/information statement and the other relevant materials when they become available before making any voting or investment decision with respect to the proposed transaction.


'/>"/>
SOURCE Thermage, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Thermage Reports Third Quarter Financial Results and Provides Information Regarding Reliants Results
2. Thermage Discloses Preliminary 3Q 2008 Results for Thermage and Reliant
3. Thermage, Inc. to Present at the Maxim Group Growth Conference
4. Thermage Announces Second Quarter 2008 Financial Results
5. Thermage, Inc. to Present at the Fourth Annual Collins Stewart Growth Conference
6. Thermage and Reliant Technologies to Join Forces
7. Thermage, Inc. to Present at the Bank of America 2008 Healthcare Conference
8. Thermage, a Leading Aesthetic Medical Device Company, Announces First Time Exhibitor Status at ACOG Meeting
9. Thermage, Inc. Announces First Quarter 2008 Results Release Date and Conference Call
10. Thermage, Inc. Announces Initial Shipments of Cellulite Product
11. Thermage Announces Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 27, 2016 , ... Quality metrics are proliferating in cancer care, and are ... the eye of the beholder, according to experts who offered insights and commentary in ... Managed Care. For the full issue, click here . , For the American ...
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology: